[Influence of cytostatic drugs on antinuclear antibodies in visceral lupus erythematosus].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis* / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002738:Chloroquine / Q000494:pharmacology; D005260:Female; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007841:Latex Fixation Tests; D008134:Long-Term Care; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010587:Phagocytosis / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000244:Adenosine Diphosphate; D002738:Chloroquine
Der Einfluss von Zytostatika auf antinukleäre Antikörper beim Lupus erythematodes visceralis